| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 23,507,000 | | Cost of Revenue | 10,336,000 | | | Gross Profit | 13,171,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 7,713,000 | | Non Recurring | 118,000 | | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 5,340,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (283,000) | | Earnings Before Interest And Taxes | 5,117,000 | | Interest Expense | 1,317,000 | | Income Before Tax | 3,800,000 | | Income Tax Expense | 674,000 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 3,126,000 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 3,126,000 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $3,126,000 |
|
1.48% Nasdaq 
Income Statement
